Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 4/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 4/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10019550 | 0.93 | HCRTR1 (0.34) | GABRA1GABRB2PDK2HCRTR1HCRTR2 | |
| SCHEMBL10020123 | 0.89 | GABRA1 (0.31) | GABRA1GABRB2 | |
| SCHEMBL15257977 | 0.86 | PDK2 (0.36) | PDK2FFAR1 | |
| SCHEMBL10019897 | 0.85 | HCRTR1 (0.32) | HCRTR1HCRTR2 | |
| SCHEMBL10020168 | 0.84 | GABRA1 (0.32) | GABRA1GABRB2PDK2 | |
| SCHEMBL10019978 | 0.84 | GABRA1 (0.37) | GABRA1GABRB2PDK2CALM1 | |
| SCHEMBL10020180 | 0.84 | PDK2 (0.33) | PDK2 | |
| SCHEMBL10019904 | 0.84 | PDK2 (0.33) | PDK2 | |
| SCHEMBL15257976 | 0.84 | S1PR1 (0.34) | S1PR1 | |
| SCHEMBL10020093 | 0.83 | HCRTR1 (0.35) | GABRA1GABRB2PDK2CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669263-B1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| WO-2012086437-A1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | JNC株式会社 (JP) | 2012-06-28 | — | — | WO | disclosed |